Literature DB >> 16270395

Surgical risk for patients with Chagasic achalasia and its correlation with the degree of esophageal dilation.

José-Garcia Neto1, Roberto de Cleva, Bruno Zilberstein, Joaquim-José Gama-Rodrigues.   

Abstract

AIM: To analyze the risk of cardiovascular complications in patients with indication for surgical treatment of Chagasic esophageal achalasia and to correlate the surgical risks with the degree of esophageal dilation, thereby proposing a risk scale index.
METHODS: One hundred and twenty-four patients with Chagasic esophageal achalasia, who received surgical treatment at the Hospital das Clinicas of the Federal University of Goias, were included in this study. The patients were mostly related to the postoperative complications due to the cardiovascular system. All the patients were submitted to: (1) clinical history to define the cardiac functional class (New York Heart Association); (2) conventional 12-lead electrocardiogram at rest; and (3) contrast imaging of the esophagus to determine esophageal dilatation according to Rezende's classification of Chagasic megaesophagus.
RESULTS: An assessment of the functional classification (FC) of heart failure during the preoperative period determined that 67 patients (54.03%) were assigned functional class I (FC I), 46 patients (37.09%) were assigned functional class II (FC II), and 11 patients (8.87%) were assigned functional class III (FC III). None of the patients were assigned to functional class IV (FC IV). There was a positive correlation between the functional class and the postoperative complications (FC IXFC II: P<0.001; FC IXFC III: P<0.001). The ECG was normal in 44 patients (35.48%) and presented abnormalities in 80 patients (64.52%). There was a significant statistical correlation between abnormal ECG (arrhythmias and primary change in ventricular repolarization) and postoperative complications (P<0.001). With regard to the classification of the Chagasic esophageal achalasia, the following distribution was observed: group II, 53 patients (42.74%); group III, 37 patients (29.83%); and group IV, 34 patients (27.41%). There was a positive correlation between the degree of esophageal dilation and the increase in postoperative complications (grade IIXgrade III achalasia: P<0.001; grade IIXgrade IV achalasia: P<0.001; and grade IIIXgrade IV achalasia: P = 0.017). Analyzing these results and using a multivariate regression analysis associated with the probability decision analysis, a risk scale was proposed as follows: up to 21 points (mild risk); from 22 to 34 points (moderate risk); and more than 34 points (high risk). The scale had 82.4% accuracy for mild risk patients and up to 94.6% for the high risk cases.
CONCLUSION: The preoperative evaluation of the cardiovascular system, through a careful anamnesis, an ECG and contrast imaging of the esophagus, makes possible to estimate the surgical risks for Chagas' disease patients who have to undergo surgical treatment for esophageal achalasia.

Entities:  

Mesh:

Year:  2005        PMID: 16270395      PMCID: PMC4479686          DOI: 10.3748/wjg.v11.i37.5840

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Authors:  T H Lee; E R Marcantonio; C M Mangione; E J Thomas; C A Polanczyk; E F Cook; D J Sugarbaker; M C Donaldson; R Poss; K K Ho; L E Ludwig; A Pedan; L Goldman
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  [Clinical and radiological aspects of aperistalsis of the esophagus].

Authors:  J de REZENDE; K M LAUAR; A de OLIVEIRA
Journal:  Rev Bras Gastroenterol       Date:  1960 Sep-Dec

3.  Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery.

Authors:  K A Eagle; B H Brundage; B R Chaitman; G A Ewy; L A Fleisher; N R Hertzer; J A Leppo; T Ryan; R C Schlant; W H Spencer; J A Spittell; R D Twiss; J L Ritchie; M D Cheitlin; T J Gardner; A Garson; R P Lewis; R J Gibbons; R A O'Rourke; T J Ryan
Journal:  Circulation       Date:  1996-03-15       Impact factor: 29.690

4.  Can ASA grade or Goldman's cardiac risk index predict peri-operative mortality? A study of 16,227 patients.

Authors:  G Prause; B Ratzenhofer-Comenda; G Pierer; F Smolle-Jüttner; H Glanzer; J Smolle
Journal:  Anaesthesia       Date:  1997-03       Impact factor: 6.955

5.  Effects of acute elevation in blood pressure and of atropine on heart rate in Chagas' disease. A preliminary report.

Authors:  D S Amorim; R A Godoy; J C Manço; A Tanaka; L Gallo
Journal:  Circulation       Date:  1968-08       Impact factor: 29.690

6.  Impact of inter-physician communication on the effectiveness of medical consultations.

Authors:  T Lee; E M Pappius; L Goldman
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

Review 7.  Perioperative cardiac risk assessment for noncardiac surgery.

Authors:  R H Mehta; E Bossone; K A Eagle
Journal:  Cardiologia       Date:  1999-05

Review 8.  Preoperative and perioperative management of cardiac patients undergoing noncardiac surgery.

Authors:  A S Blaustein
Journal:  Cardiol Clin       Date:  1995-05       Impact factor: 2.213

Review 9.  Preoperative laboratory testing: should any tests be "routine" before surgery?

Authors:  D S Macpherson
Journal:  Med Clin North Am       Date:  1993-03       Impact factor: 5.456

10.  Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas' disease.

Authors:  R B Bestetti; O C Freitas; G Muccillo; J S Oliveira
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

View more
  1 in total

1.  Laparoscopic stapled cardioplasty for end-stage achalasia.

Authors:  Ewen A Griffiths; Peter G Devitt; Glyn G Jamieson; Jennifer C Myers; Sarah K Thompson
Journal:  J Gastrointest Surg       Date:  2012-12-12       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.